股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年3月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 天德化工控股有限公司 呈交日期: 2026年4月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00609 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | ...

第 2 頁 共 2 頁 v 1.1.1 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 天德化工控股有限公司 | | 股份代號 | 00609 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 截至二零二五年十二月三十一日止年度之末期股息 | | | 公告日期 | 2026年3月23日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息類型 | 末期 | | 股息性質 | 普通股息 | | 財政年末 | 2025年12月31日 | | 宣派股息的報告期末 | 2025年12月31日 | | 宣派股息 | 每 股 0.03 HKD | | 股東批准日期 | 2026年6月5日 | | 香港過戶登記處相關信息 | | | 派息金額及公司預設派發貨幣 | 每 股 0.03 HKD | | 匯率 | 1 ...

Revenue and Profitability - Revenue increased slightly by 1.2% to approximately RMB 1,895,600,000 for the year ended December 31, 2025, compared to RMB 1,873,800,000 in 2024[2] - Gross profit rose by 1.7% to approximately RMB 231,300,000, with a gross margin of 12.2%, up from 12.1% in 2024[2] - Profit attributable to owners decreased to approximately RMB 62,500,000, down from RMB 66,900,000 in 2024[2] - EBITDA increased by 5.5% to approximately RMB 262,800,000, compared to RMB 249,100,000 in 2024[2] - Basic earnings per share were approximately RMB 0.070, down from RMB 0.077 in 2024[2] - The company experienced slight year-on-year revenue growth despite ongoing price competition and a challenging economic environment[26] - Average raw material costs decreased, but the decline was less than the drop in selling prices, impacting overall profitability[27] Assets and Liabilities - Total assets decreased to RMB 2,457,412,000 from RMB 2,559,926,000 in 2024[4] - Current assets net value decreased to RMB 789,825,000 from RMB 900,681,000 in 2024[4] - Non-current assets increased slightly to RMB 1,667,587,000 from RMB 1,659,245,000 in 2024[4] - Trade receivables and notes receivable as of December 31, 2025, totaled RMB 325,657,000, a decrease from RMB 377,774,000 in 2024[20] - Trade payables as of December 31, 2025, amounted to RMB 29,038,000, down from RMB 37,901,000 in 2024[22] - Short-term bank borrowings increased to approximately RMB 333,700,000 from RMB 220,100,000 in 2024, primarily used for general operating funds[37] - The net cash balance as of December 31, 2025, was approximately RMB 486,500,000, down from RMB 626,900,000 in 2024, indicating a focus on maintaining a stable financial position[39] Expenses and Costs - Total employee costs decreased to RMB 170,212,000 in 2025 from RMB 189,558,000 in 2024, a reduction of about 10.2%[15] - Selling expenses rose to approximately RMB 85,600,000, an increase of RMB 14,500,000 from RMB 71,100,000 in 2024, representing 4.5% of total revenue compared to 3.8% in 2024[32] - Administrative and other operating expenses decreased to approximately RMB 108,800,000 from RMB 137,800,000 in 2024, accounting for 5.7% of total revenue, down from 7.4%[33] - Financial costs increased to approximately RMB 11,100,000 from RMB 3,700,000 in 2024, reflecting a rise of RMB 7,400,000 due to increased reliance on bank loans and financing arrangements[34] Dividends - The board proposed a final dividend of HKD 0.03 per share, consistent with the previous year[2] - The proposed final dividend for the year is HKD 0.03 per share, unchanged from the previous year, while the total dividend paid for 2024 was RMB 96,630,000[18] - The proposed final dividend for the year ended December 31, 2025, is HKD 0.03 per share, consistent with the dividend for 2024[23] Market and Economic Conditions - The group reported a total comprehensive income of RMB 27,713,000, down from RMB 47,227,000 in 2024[3] - The revenue breakdown by region shows that local sales in China were RMB 1,316,868,000, a decrease of 2.2% from RMB 1,347,122,000 in 2024[13] - The group’s total revenue from international markets included RMB 203,073,000 from India and RMB 62,560,000 from the UAE, with the US revenue decreasing to RMB 38,726,000 from RMB 66,631,000 in 2024[13] - Geopolitical tensions and rising global trade protectionism are expected to exert unprecedented pressure on the export performance of domestic manufacturing[28] - The Chinese government is prioritizing the resolution of structural supply-demand imbalances, which may lead to a healthier market ecosystem[28] - Companies with cost advantages and stronger operational resilience are anticipated to benefit from industry restructuring and gain growth opportunities[28] Future Outlook and Commitments - The company is strategically reallocating resources to accelerate overseas market expansion in response to weak domestic demand[26] - The company plans to continue developing new products and optimizing production facilities to ensure sustainable business growth while maintaining a strong financial status[39] - The company has unprovided commitments of approximately RMB 104,800,000 related to the acquisition of properties, plants, and equipment as of December 31, 2025, down from RMB 140,300,000 in 2024[42] - The company has approved but uncontracted capital commitments of approximately RMB 204,600,000 as of December 31, 2025, compared to RMB 169,500,000 in 2024[42] - The company has not utilized any financial instruments for foreign exchange hedging due to minimal currency risk, as most transactions are conducted in RMB[43] - The company has maintained a prudent financing and treasury policy to minimize financial risks and ensure sufficient cash flow for operations and future investments[43] Employment and Workforce - The company had a total of 1,190 full-time employees as of December 31, 2025, down from 1,358 in 2024[45] - The total employee costs, including director remuneration, decreased to approximately RMB 170,200,000 in the review year, compared to RMB 189,600,000 in 2024[46] Compliance and Audit - The audit committee has reviewed the financial statements and found no unusual items, confirming compliance with accounting policies[51] - There were no significant post-reporting events after December 31, 2025, up to the announcement date[48] Accounting Standards - The group is currently evaluating the impact of new accounting standards effective from January 1, 2027, which may significantly affect the presentation and disclosure of financial statements[10]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部份 內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （ 在開曼群島註冊成立之有限公司 ） （股份代號: 609） 董事會會議通告 天德化工控股有限公司（「本公司」）董事會（「董事會」）謹此公佈本公司將於二零二六 年三月二十三日（星期一）於香港中環夏慤道 12 號美國銀行中心 2204A 室舉行董事會 會議，以考慮並（若認為合適）批准（其中包括）本公司及其附屬公司截至二零二五年 十二月三十一日止之經審核年度業績及其公佈，以及宣派及支付末期股息（如有）。 承董事會命 天德化工控股有限公司 劉偉珍 公司秘書 Tiande Chemical Holdings Limited 天德化工控股有限公司 香港, 二零二六年三月六日 於本公告日期，執行董事為劉楊先生、陳孝華先生及竇奧博先生；非執行董事為王子 江先生；獨立非執行董事為梁錦雲先生、劉晨光先生及山紅紅女士。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年2月28日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 天德化工控股有限公司 呈交日期: 2026年3月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00609 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 天德化工控股有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00609 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | 本月底法定/註冊股本總額： HK ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 天德化工控股有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00609 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | ...

Tiande Chemical Holdings Limited 天德化工控股有限公司 (在開曼群島註冊成立之有限公司) (股份代號: 609) 董事名單與其角色和職能 自二零二六年一月一日起，天德化工控股有限公司董事會（「董事會」）成員載列如下： 執行董事 香港，二零二五年十二月三十一日 劉楊先生 （主席） 陳孝華先生 竇奧博先生 非執行董事 王子江先生 獨立非執行董事 梁錦雲先生 劉晨光先生 山紅紅女士 董事會設立四個委員會，下表提供各董事會成員在這些委員會中所擔任的職位： | 董事委員會 | | | | | | --- | --- | --- | --- | --- | | 董事╱ | | | | 安全及環保委 | | 管理層 | 審核委員會 | 薪酬委員會 | 提名委員會 | 員會 | | 劉楊先生 | - | M | C | C | | 山紅紅女士 | M | M | M | M | | 梁錦雲先生 | C | M | M | - | | 劉晨光先生 | M | C | M | - | | 李玉國先生 | - | - | - | M | 附註: C: 有關委員會的主席 M: 有關委員會的成員 ...

Core Viewpoint - Tian De Chemical (00609.HK) announced a share transfer agreement where it will acquire a 49% stake in Weifang Zhongying Chemical Co., Ltd. for RMB 88 million, making it an indirect wholly-owned subsidiary after completion [1] Group 1 - The buyer is Weifang Binhai Petrochemical Co., Ltd., a wholly-owned subsidiary of the company [1] - The seller is Zhejiang Zhongshan Chemical Group Co., Ltd. [1] - The target company primarily engages in the research, development, manufacturing, and sales of chemical products [1]

Core Viewpoint - Tian De Chemical (00609) has announced the acquisition of a 49% equity stake in Weifang Zhongying Chemical Co., Ltd. for RMB 88 million, aiming to enhance its position in the fine chemical industry and improve operational efficiency [1] Group 1: Acquisition Details - The buyer, Weifang Binhai Petrochemical Co., Ltd., is a wholly-owned subsidiary of the company [1] - The seller, Zhejiang Zhongshan Chemical Group Co., Ltd., has agreed to sell the stake, which will make the target company a wholly-owned subsidiary of the company upon completion [1] Group 2: Strategic Rationale - The acquisition is part of the company's strategy to strengthen its position in the fine chemical sector amid significant operational challenges in China's manufacturing industry [1] - The company aims to streamline decision-making processes and align the target company's operations with its long-term growth strategy through full integration [1] Group 3: Growth Opportunities - By fully integrating the target company, the group plans to leverage its strong capabilities, competitive advantages, industry expertise, and existing customer relationships to pursue additional growth opportunities [1] - This move supports the company's commitment to disciplined expansion and operational excellence, ultimately creating sustainable value for shareholders [1]